| Literature DB >> 11821157 |
Yoshihiro Kobayashi1, Haruhiro Yukiue, Hidefumi Sasaki, Ichiro Fukai, Tomoki Yokoyama, Masanobu Kiriyama, Yosuke Yamakawa, Masanobu Maeda, Yoshitaka Fujii.
Abstract
Survivin is a member of the inhibitor-of-apoptosis (IAP) family. It has been reported to be expressed during development, but not in differentiated normal tissue. However, its expression has been reported to be high in the thymus. To assess the role of survivin in human thymocyte development, we investigated the expression of survivin using reverse-transcriptase-polymerase chain reaction, flow cytometry, and immunohistochemistry in freshly isolated human thymocytes. Survivin was expressed in all thymocyte subsets but its expression level was developmentally regulated. Its expression was low in the double negative (DN) thymocytes, upregulated in double positive (DP) thymocytes, and was highest in the T-cell receptor(high), late DP thymocytes; it was then downregulated in the single positive thymocytes and negative in the peripheral blood T cells. Moreover, there was a positive correlation between the expression of survivin and that of CD69 and Bcl-2 in DP thymocytes. These results suggest that survivin may play an important role in the T-cell development in the human thymus.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11821157 DOI: 10.1016/s0198-8859(01)00369-x
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850